Condition: Subarachnoid Hemorrhage · Critical Illness · Infusion Fluid · Sponsor: Insel Gruppe AG, University Hospital Bern
Patients with subarachnoid hemorrhage are prone to suffer from dysnatriemia. Evidence shows that hyponatriemia is associated with increased incidence of vasospasm, brain swelling and mortality in these patients. Patients with subarachnoid hemorrhage often require large amounts of iv fluids in order to maintain euvolemia and support cardiocirculatory function. Prior evidence shows that the type of infusion fluid significantly influences blood sodium content. Hence, this study evaluated whether the sodium content of the infusion solution impacts mortality and morbidity in patients with subarachnoid hemorrhage.
This description comes directly from the study's public registry record.
Anna S Messmer, MD · +41316322111 · anna.messmer@insel.ch
Research Nurses Department of Intensive Care · +41316322111 · kim.researchnurses@insel.ch
Always discuss trial participation with your own doctor first.
| Department of perioperative Intensive Care Medicine | Sankt Gallen, Canton of St. Gallen, Switzerland | Recruiting |
| Department of Intensive Care, Bern University Hospital and University of Bern, Bern, Switzerland | Bern, Switzerland | Recruiting |
| Department of Intensive Care Medicine | Geneva, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04043598